Tagged Articles

Sonafi SA 2 articles

Federal judge establishes settlement committees for Taxotere MDL

Hundreds of Taxotere lawsuits are consolidated in multidistrict litigation (MDL) in federal court in Louisiana. The complaints allege Taxotere, a chemotherapy drug used to treat many kinds of cancers including breast, lung, prostate, stomach, and head and neck cancer, can cause permanent hair loss. The manufacturer of the drug, Sonafi SA, is accused of illegally, untruthfully marketing Taxotere as superior to similar competing drugs, while concealing from American consumers the drug’s risk of irreversible alopecia. “The company knew, at least as early as the late 1990s, of a study showing that 9.2 percent of people who took the drug lost ... Read More

Lawsuits against chemotherapy drug Taxotere consolidated in Louisiana

Thirty-three cases that had been filed federally across the U.S. against pharmaceutical company Sanofi SA were consolidated this month into a multidistrict litigation (MDL) in Louisiana district court, according to Law360. The drug maker is accused of marketing its chemotherapy drug Taxotere as superior to similar competing drugs, while concealing that the drug caused permanent hair loss. Law360 quotes from one of the suits filed by Ami Dodson in California saying that Sonafi SA began misrepresenting the safety and effectiveness of Taxotere as early as 1996, the year that the drug was approved for use by the Food and Drug ... Read More